Cargando…
Comparative Evaluation of Nephrotoxicity and Management by Macrophages of Intravenous Pharmaceutical Iron Formulations
BACKGROUND: There is a significant clinical need for effective treatment of iron deficiency. A number of compounds that can be administered intravenously have been developed. This study examines how the compounds are handled by macrophages and their relative potential to provoke oxidative stress. ME...
Autores principales: | Connor, James R., Zhang, Xuesheng, Nixon, Anne M., Webb, Becky, Perno, Joseph R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431721/ https://www.ncbi.nlm.nih.gov/pubmed/25973894 http://dx.doi.org/10.1371/journal.pone.0125272 |
Ejemplares similares
-
Ferrous iron content of intravenous iron formulations
por: Gupta, Ajay, et al.
Publicado: (2016) -
Iron infusion and newer intravenous iron formulations
por: Aung, Tim, et al.
Publicado: (2021) -
Pharmaceutical iron formulations do not cross a model of the human blood-brain barrier
por: Chiou, Brian, et al.
Publicado: (2018) -
Administration of Intravenous Iron Formulations Induces Complement Activation in-vivo
por: Faria, Bernardo, et al.
Publicado: (2019) -
Critical review on the pharmaceutical vistas of Lauha Kalpas (Iron formulations)
por: Gupta, K.L. Virupaksha, et al.
Publicado: (2012)